Clinical trial
A Phase III Single-Blind, Randomized, Placebo Controlled, Clinical Trial to Determine the Safety and Efficacy of Intravenous L-Citrulline Versus Placebo in Children Undergoing Cardiopulmonary Bypass
NCT00335244 is registered in ClinicalTrials.gov with Asklepion Pharmaceuticals, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase III Single-Blind, Randomized, Placebo Controlled, Clinical Trial to Determine the Safety and Efficacy of Intravenous L-Citrulline Versus Placebo in Children Undergoing Cardiopulmonary Bypass
- Lead sponsor
- Asklepion Pharmaceuticals, LLC
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 31, 2006
- Completion date
- December 31, 2009
- Enrollment
- 77 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.